Submit an abstract for the Spotlight on Immuno-Oncology conference by June 2, 11:59 p.m. PT
Board member Rayne Rouce, MD, spoke to three ASGCT leaders about their 26th Annual Meeting experiences.
What do ASGCT leaders think of the Annual Meeting (and basketball)? This year, Rayne Rouce, MD, ASGCT's 2021-2024 at-large director, spoke to the current and two future presidents to find out.
Watch the three daily recaps below and remember: All recorded sessions from the 26th Annual Meeting are available on demand through June 23! Watch them now on our virtual platform—or register by June 19 to get access.
ASGCT's Vice President Paula Cannon, PhD, shares her impressions of the second day of the 26th Annual Meeting. Hear the highlights of her Wednesday—and what she's looking forward to at the rest of the conference and in Los Angeles.
ASGCT's President Hans-Peter Kiem, MD, PhD, talks about the third day of the 26th Annual Meeting. Hear the highlights of his Thursday—and why he values the opportunities the conference provides.
ASGCT's incoming President Jeffrey Chamberlain, PhD, talks about the 26th Annual Meeting. Hear his highlights from the meeting and vision for the next year.
We hope you enjoyed your Annual Meeting experience. See you next year in Baltimore, MD, between May 7-11, 2024!
Sept. 18-19 | Washington, DC
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico